MICELI, DEBRAH – Trademark Portfolio
Entity Type: 01
MICELI, DEBRAH holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. The portfolio also extends into Class 25 (Clothing) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MADUSA, RAW YOGA, and F.I.T. FEMININE INTELLIGENT TOUGH. The owner is based in HOMOSSASSA, FL.
4585 SOUTH TRENT TERRACE
HOMOSSASSA, FL 34446
Showing of trademarks Trademarks
Trademark Classifications
MICELI, DEBRAH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does MICELI, DEBRAH have?
MICELI, DEBRAH has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does MICELI, DEBRAH file in?
MICELI, DEBRAH files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 25 (Clothing), Class 44 (Medical Services), Class 28 (Toys & Sporting Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are MICELI, DEBRAH's most well-known trademarks?
MICELI, DEBRAH's registered trademark portfolio includes well-known marks such as MADUSA, RAW YOGA, and F.I.T. FEMININE INTELLIGENT TOUGH. These are among 3 currently registered trademarks in the portfolio.
What is MICELI, DEBRAH's trademark registration success rate?
MICELI, DEBRAH has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.